On 2025-04-29, Kiniksa Pharmaceuticals, Ltd. (KNSA) announced earnings per share of $0.11 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $0.02.
The next expected annoucement date for quarterly earnings is 2025-07-22, with an average estimated earnings per share of $0.18 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-04-29 | 2025-03-31 | $0.02 | $0.11 |
| 2025-02-25 | 2024-12-31 | $-0.06 | $-0.12 |
| 2024-10-29 | 2024-09-30 | $-0.01 | $-0.18 |
| 2024-07-23 | 2024-06-30 | $-0.09 | $-0.06 |
| 2024-04-23 | 2024-03-31 | $-0.14 | $-0.25 |
| 2024-02-28 | 2023-12-31 | $-0.11 | $0.04 |
| 2023-10-31 | 2023-09-30 | $-0.18 | $-0.20 |
| 2023-07-25 | 2023-06-30 | $-0.16 | $-0.02 |
| 2023-05-02 | 2023-03-31 | $-0.18 | $-0.18 |
| 2023-02-28 | 2022-12-31 | $-0.24 | $0.06 |
| 2022-11-01 | 2022-09-30 | $0.38 | $0.67 |
| 2022-08-03 | 2022-06-30 | $-0.43 | $-0.29 |
| 2022-05-03 | 2022-03-31 | $-0.52 | $-0.36 |
| 2022-02-22 | 2021-12-31 | $-0.44 | $-0.53 |
| 2021-11-01 | 2021-09-30 | $-0.63 | $-0.44 |
| 2021-08-03 | 2021-06-30 | $-0.69 | $-0.61 |
| 2021-05-04 | 2021-03-31 | $-0.73 | $-0.72 |
| 2021-02-23 | 2020-12-31 | $-0.61 | $-0.79 |
| 2020-11-05 | 2020-09-30 | $-0.59 | $-0.66 |
| 2020-07-30 | 2020-06-30 | $-0.55 | $-0.65 |
| 2020-04-28 | 2020-03-31 | $-0.62 | $-0.48 |
| 2020-02-26 | 2019-12-31 | $-0.57 | $-0.58 |
| 2019-10-28 | 2019-09-30 | $-0.74 | $-0.49 |
| 2019-08-12 | 2019-06-30 | $-0.72 | $-0.68 |
| 2019-05-02 | 2019-03-31 | $-0.85 | $-1.27 |
| 2019-03-07 | 2018-12-31 | $-0.74 | $-0.88 |
| 2018-11-01 | 2018-09-30 | $-0.50 | $-0.51 |
| 2018-08-06 | 2018-06-30 | $-0.53 | $-0.97 |